Abbvie Stock Analysis ABBV stock 4 Dividend Yield
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=_gH_2lkzUvM
ABBVIE stock, ticker symbol ABBV. This stock is down almost 3% year to date, underperforming the SP500 which returned nearly 12%. • Abbvie reported a beat on EPS and revenue most recently and for the upcoming earnings, all analyst expect another beat. • People love Abbvie stock for different reasons, and one of them is the dividend, and I understand why with dividend yield at almost 4%, and 10 years of dividend increases. • If we look at the total returns in the past 5 years, we see that Abbvie stock massively outperforms the SP500. • So could this be the perfect time to buy Abbvie stock? • Well by the end of the video I’ll give you my three price targets. So make sure to stay tuned and see how I build up to these price targets. • I’m very excited to see what you guys think about this stock, so please let me know your thoughts in the comments. • My name thomas and this thomas invest. I’m investor looking for great stocks at great prices. • What does ABBVIE do? • AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. • In this video: • 00:00 - Abbvie Stock • 01:06 - Abbvie Earnings • 03:29 - Abbvie Fundamentals • 06:30 - Abbvie Dividends • 08:01 - Abbvie Returns • 09:05 - Abbvie Price target • 10:46 - Conclusion • Discord channel: / discord • If you have some feedback for me or the video, please let me know! • Please LIKE, COMMENT, and SUBSCRIBE for more! • DISCLAIMER: • Remember to always do your own research and never fully trust on what I, or other Youtubers, say about a stock. I’m not a financial advisor and this content is just for entertaining purposes only. • Screenshots are taken within the Everythingmoney software, please check out there channel, their software is the best! • Hashtags: • #abbvie #abbv #healthstock #dividendstock #dividends #dividend #dividendincome #dividendstrategy #dividendportfolio #dividendgrowth #dividendinvesting #dividendgrowth
#############################